Skip to content
You are now leaving https://www.ionispharma.com to visit

Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR

  Akcea shareholders approved the transaction on April 16 at a Special Meeting of Stockholders                              Ionis licenses Akcea worldwide rights to inotersen and AKCEA-TTR-L Rx                CAMBRIDGE, Mass. and CARLSBAD, Calif., April 17, 2018 (GLOBE NEWSWIRE) —  Akcea